Evidence map›Paper›PMID 40579539›Full record

ArticleNature genetics2025

Author Correction: Incorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design.

Jakob German, Zhiyu Yang, Sarah Urbut, Pekka Vartiainen, FinnGen, Pradeep Natarajan, Elisabetta Patorno, Zoltan Kutalik, Anthony Philippakis, Andrea Ganna

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jakob GermanInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0009-0002-1257-7782
Zhiyu YangInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-8074-838X
Sarah UrbutDivision of Cardiovascular Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1135-9647
Pekka VartiainenInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0001-5803-9571
FinnGen
Pradeep NatarajanCenter for Genomic Medicine Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8402-7435
Elisabetta PatornoCardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-8809-9898
Zoltan KutalikUniversity Center for Primary Care and Public Health, Lausanne, Switzerland.ORCID http://orcid.org/0000-0001-8285-7523
Anthony PhilippakisEric and Wendy Schmidt Center, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Andrea GannaInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. andrea.ganna@helsinki.fi.ORCID http://orcid.org/0000-0002-8147-240X

Funding

Novel approaches to improve comparative effectiveness research of medical and surgical weight reduction strategies in clinical practiceR01DK138036 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI Elisabetta Patorno · 2024 to 2026
$2.3M
NIDDK NIH HHS R01 DK138036
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40579539
PMCPMC12339395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.